CHX experiments confirmed this speculation, demonstrating that MLC1 expression in U251 astrocytoma cells is able to increase stability of Cx43 proteins at the plasma membrane, as indicated by its slower degradation time in WT when compared to MLC1 mutant-expressing cells. This evidence concerns the gene MLC1 and astrocytoma (excluding glioblastoma).